Search Results 261-270 of 17294 for Cyclophosphamide

1. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   alkylators (e.g., melphalan, cyclophosphamide) and anthracyclines ≤ 14 days prior to registration;; high dose corticosteroids and immunomodulatory drugs ...

2. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   Note: a) Subjects who have received a cyclophosphamide (CYC) induction ... Cyclophosphamide: oral CYC within 2 weeks prior to Baseline (Visit 2) and IV ...

3. Etanercept (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Do not take other medicines unless they have been discussed with your doctor. This includes abatacept (Orencia®), anakinra (Kineret®), or cyclophosphamide ( ...

4. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

   ... cyclophosphamide, IVIg, anti-TNF agents, and rituximab). Subjects with an MMT-8 score ≤ 66 (see Appendix B) must also have at least 2 other core set ...

5. Recurrent Breast Cancer Clinical Trials - Mayo Clinic Research

   ... cyclophosphamide and paclitaxel, reduces the risk of recurrence (called disease-free survival) compared to standard chemotherapy alone. Combination ...

6. Natalizumab-sztn (intravenous route) - Side effects & uses - Mayo Clinic

   ... cyclophosphamide, cyclosporine, mercaptopurine, methotrexate, mitoxantrone, mycophenolate mofetil, or steroid medicine) before receiving this medicine.

7. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

   ... Cyclophosphamide Rochester, MN. The purpose of this study is to look at the effectiveness of using a study drug called cyclophosphamide (PTCy) to prevent ...

8. Pediatric Brain Tumors Clinical Trials - Mayo Clinic Research

   Chemotherapy drugs such as cyclophosphamide, topotecan, cisplatin, etoposide, vincristine, dexrazoxane, doxorubicin, temozolomide, irinotecan and ...

9. A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects with Early Stage Triple Negative Breast Cancer - Mayo Clinic

   Previous treatment with carboplatin, paclitaxel, doxorubicin, cyclophosphamide and a Poly-(ADP-ribose)-Polymerase (PARP) inhibitor. Concurrent treatment ...

10. Breast Cancer Clinical Trials - Mayo Clinic Research

    RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamide, and paclitaxel, work in different ways to stop the growth of tumor cells, either ...